Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

NCT06230016 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-02-16
Last updated
2026-05-20

Condition(s) studied

Childhood CancerAdapted Physical Activity

Investigational drug(s) / intervention(s)

questionnairesPedsQL quality of life questionnaires

questionnaires: human and social science questionnaire (specifically designed by the expert lab of Grenoble) on motivation and restraint perceived by patient and parents, elaborated especially for this study. Questionnaire administred before the start of current care APA programm and after 4 to 6 months.

PedsQL quality of life questionnaires: validated PedsQL (The Pediatric Quality of Life Inventory) questionnaires administred to children (if adequate) and parents before the start of current care APA programm and after 4 to 6 months

Study summary

Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse.

The aim of this study is to keep the children in the APA programm during all the treatment lenght.

This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm.

The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents

Eligibility

Sex
ALL
Min age
3 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 3 years to under 18 years under care at Grenoble Alpes University Hospital * New cancer diagnosis or relapse in the absence of previous APA treatment * All cancer pathologies: Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors * Regardless of therapeutic pathway * Parents and patient over 5 years old understanding french langage * Patient and parents who have not objected to participation after being informed Exclusion Criteria: * Patient with a strict medical contraindication to physical activity identified by the referring physician or another specialist physician, particularly the sports physician (unstabilized heart or lung disease, uncontrolled diabetes, etc.)

Primary outcome measure(s)

  • Adhesion to an APA programm — 4 to 6 months
    Adherence of children and adolescents undergoing cancer treatment to personalized support in Adapted Physical Activity \[APA\] offered at an early stage and for a minimum duration of 4 to 6 months : patients following the whole APA program/patients included, in percent

Trial sites (1)

FacilityCityRegionStatus
CHU Grenoble Alpes Grenoble ISERE
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06230016 on ClinicalTrials.gov ↗ ← All trials in France